IYH Fees and Costs — iShares U.S. Healthcare ETF
Data updated: 2026-09-23
The net expense ratio is 0.37%. There are no sales loads or redemption fees. In fiscal 2026 the fund paid $12K in broker commissions, 0.0004% of average net assets, and portfolio turnover was 3%.
IYH Fees and Expenses
Annual operating expenses and sales charges of IYH. Prospectus, as of April 30, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.37% |
| 12b-1 fee | — |
| Other expenses | 0.00% |
| Gross expense ratio | 0.37% |
| Fee waiver | — |
| Net expense ratio | 0.37% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
IYH Costs Over Time
On $10,000 invested in IYH, assuming 5% a year before costs, total costs come to $235 over 5 years, cutting the return by 0.39% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.37%) | $39 | $122 | $213 |
| Trading costs (broker commissions) | $0 | $0 | $0 |
| Lost growth on money paid in costs | $0 | $6 | $21 |
| Total costs | $39 | $128 | $235 |
| Value after costs | $10,461 | $11,448 | $12,528 |
| Impact on return, per year | 0.39% | 0.39% | 0.39% |
IYH Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending April 30, 2026.
- Explicit cost rate (commissions ÷ average net assets): 0.0004%
- Total broker commissions: $12K
- Bought from dealers (principal trades, not a cost): $3.0B
- Portfolio turnover (prospectus): 3%
- Securities on loan, average value: $23.2M
- Net income from securities lending: $78K (0.003% of average net assets)
IYH Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| UBS Securities LLC | $3K | 27.86% |
| BofA Securities, Inc. | $2K | 19.85% |
| BNP Paribas Securities Corp. | $1K | 12.54% |
| Barclays Capital Inc. | $1K | 11.23% |
| Oppenheimer & Co. Inc. | $687 | 6.41% |
| Goldman Sachs & Co. LLC | $559 | 5.22% |
| RBC Capital Markets, LLC | $507 | 4.73% |
| Cantor Fitzgerald & Co. | $483 | 4.51% |
| J.P. Morgan Securities LLC | $466 | 4.35% |
| Wells Fargo Securities, LLC | $353 | 3.29% |
IYH Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Goldman Sachs & Co. LLC | $640.2M | 21.26% |
| Jane Street Capital, LLC | $488.1M | 16.21% |
| Virtu Americas LLC | $477.0M | 15.84% |
| BofA Securities, Inc. | $409.1M | 13.58% |
| RBC Capital Markets, LLC | $377.1M | 12.52% |
| Citigroup Global Markets Inc. | $193.9M | 6.44% |
| Citadel Securities LLC | $183.0M | 6.08% |
| BNP Paribas Securities Corp. | $105.2M | 3.49% |
| ABN Amro Securities (USA) LLC | $93.3M | 3.10% |
| UBS Securities LLC | $44.7M | 1.49% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.